Results 241 to 250 of about 5,109,346 (334)

Treatment Strategies for Hepatic Metastases From Pancreatic Cancer in Patients Previously Treated With Radical Resection Combined With Intraoperative Radiation Therapy [PDF]

, 1994
Hiroshi Takamori, Takehisa Hiraoka, Keiichirou Kanemitsu, Tatsuya Tsuji, Naoyuki G. Saito, Hidefumi Nishida, Hisashi Sakaguchi, Yoshimasa Miyauchi   +7 more
openalex   +1 more source

Anisotropic Surface Microrollers for Endovascular Navigation: A Computational Analysis with a Case Study in Hepatic Perfusion

Advanced Theory and Simulations, EarlyView.
Computational fluid dynamics analyses assess the upstream locomotion performance of anisotropic microrollers with varying height‐to‐width ratios. Observing their successful upstream locomotion in veins, their performance in hepatic circulation is investigated for treating primary liver cancer.
Burak Arslan, Ugur Bozuyuk, Kıvanç Görgülü, Erdost Yildiz, Hakancan Ozturk, Lucia Liotta, Volker Heinemann, Hana Algül, Metin Sitti   +8 more
wiley   +1 more source

Advances in pancreatic cancer epigenetics: From the mechanism to the clinic. [PDF]

World J Gastrointest Oncol
Zhou JD, Shen HZ.
europepmc   +1 more source

INTRAARTERIAL INFUSION CHEMOTHERAPY FOR IRRESECTABLE PANCREATIC CANCER BY USING ANGIOTENSIN II AND PROSTAGLANDIN E₁

, 1984
Hiroaki Ohigashi, Osamu Ishikawa, Takeru Ichikawa, Y Sasaki, Shingi Imaoka, Takeshi Iwanaga, Y Hasegawa, S Nakano   +7 more
openalex   +2 more sources

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47

Advanced Science, EarlyView.
Cancer cell‐intrinsic SMYD3 orchestrates an immunosuppressive microenvironment and impairs the response to PD‐1 blockade by reprogramming immune cells landscape in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC). The immunomodulatory function of SMYD3 is mediated via the SREBP1/CD47 pathway.
Zhengfang Liu, Xiumei Zhao, Maolin Zang, Huiyang Yuan, Xin Qin, Xiaofeng Li, Shuo Zhao, Ruirong Tan, Keqiang Yan, Li Liu, Yidong Fan, Ning Zhang, Benkang Shi, Bo Han, Shouzhen Chen   +14 more
wiley   +1 more source

Recent Findings in N6-Methyladenosine Modification and Significance in Pancreatic Cancer. [PDF]

Cancer Med
Hara T, Meng S, Arao Y, Saito Y, Inoue K, Rennie S, Ofusa K, Kitagawa T, Ishii H.   +8 more
europepmc   +1 more source

B1. EARLY DIAGNOSIS OF PANCREATIC CANCER

, 1984
Muneaki ABE
openalex   +2 more sources

Multivariate Screening and Automated Clustering of Macrophage Immunoreactome to Nanoparticles and Photothermal Therapy

Advanced Science, EarlyView.
Predicting immune responses to treatments, including nanomedicines, with high throughput test is challenging due to the immunoreactome's complexity and plasticity. A predictive screening platform integrating pathway activation and gene profiling in macrophages has been developed as a versatile tool for designing effective immunotherapies.
Sonia Becharef, Léa Jabbour, Nassima Bekaddour, Giulio Avveduto, Nathalie Luciani, Gautier Laurent, Rana Bazzi, Edouard Alphandery, Stéphane Roux, Amanda K. A. Silva, Kelly Aubertin, Jean‐Philippe Herbeuval, Florence Gazeau   +12 more
wiley   +1 more source

Pancreatic Cancer Mimicking Relapse of Autoimmune Pancreatitis: Case Reports. [PDF]

Surg Case Rep
Kojima H, Kitago M, Iwasaki E, Masugi Y, Abe Y, Hasegawa Y, Hori S, Tanaka M, Nakano Y, Edanami M, Ueno A, Kitagawa Y.   +11 more
europepmc   +1 more source

Brain and Skull Metastases of Hepatic or Pancreatic Cancer

, 1990
Jun‐ichi Kuratsu, Masaji Murakami, Shozaburo UEMURA, Yukitaka Ushio   +3 more
openalex   +2 more sources